FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series B / Biotech startups that raised Series B in Cambridge, Massachusetts

Biotech startups that raised Series B in Cambridge, Massachusetts

Updated 16 Nov 2026

Reset
Biotech startups that raised Series B in Cambridge, Massachusetts
One-time CSV
  • 68 funded companies, 65 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-b~cambridge-massachusetts.csv68 rows × 18 columns
CompanyCityLast roundAmountDate
SimnovaCambridgeSeries B$59.3M2026-08-18
Elemental MachinesCambridgeSeries B$5.7M2026-05-27
KytopenCambridgeSeries B$1.6M2026-04-07
Atavistik BioCambridgeSeries B$40.0M2026-03-05
Nocion TherapeuticsCambridgeSeries B$23.0M2026-01-07
PineTree TherapeuticsCambridgeSeries B$47.0M2025-10-28
ARTBIOCambridgeSeries B$132.0M2025-07-29
AIRNACambridgeSeries B$155.0M2025-04-01

8 rows of the CSV in 5 of its 18 columns.

68
Startups
$7.9B
Total raised
12
Funded in the last 12 months
$738.1M
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

9 of 68
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
Elemental Machines Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. Artificial intelligence Series B $5.7M 2026-05-27 $66.5M Founders Fund, Tau Ventures, Rock Health Capital +2 11 to 50 2015
Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017
Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
AIRNA AIRNA develops RNA editing technologies to create medicines for various diseases. Biotech Series B $155.0M 2025-04-01 $245.0M ARCH Venture Partners, Alexandria Venture Investments, Forbion Capital Partners +2 51 to 100 2021
NextPoint Therapeutics NextPoint Therapeutics develops therapeutics to treat cancer patients as a clinical-stage biotechnology company. Biotech Series B $42.5M 2024-02-14 $122.5M Invus, Leaps by Bayer, Catalio Capital Management +2 51 to 100 2020
ROME Therapeutics ROME Therapeutics develops therapies for cancer and autoimmune diseases by targeting the repeatome. Biotech Series B $72.0M 2023-09-12 $199.0M Andreessen Horowitz, Google Ventures, Alexandria Venture Investments +2 11 to 50 2020
InsideTracker InsideTracker provides a platform that analyzes and tracks key biochemical and physiological markers. Biotech Series B $15.0M 2022-09-06 $18.2M OurCrowd, MassVentures, Puget Sound Venture Club +2 11 to 50 2009

Table 1. Biotech startups that raised Series B in Cambridge, Massachusetts: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 68.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Simnova Simnova Biotherapeutics develops CAR-based cell therapies for treating cancer. Biotech Series B $59.3M 2026-08-18 $87.2M Oriza Seed Capital (Oriza Yuandian), Youshan Capital, PagodaTree Partners +1 51 to 100 2019
2 Atavistik Bio Atavistik Bio develops precision allosteric small molecules to treat metabolic diseases and cancer. Biotech Series B $40.0M 2026-03-05 $260.0M Lux Capital, The Column Group, Nextech Invest 11 to 50 2021
3 Nocion Therapeutics Nocion Therapeutics develops pharmaceuticals to treat conditions arising from neurogenic inflammation. Biotech Series B $23.0M 2026-01-07 $134.0M Canaan Partners, F-Prime, OUP (Osage University Partners) +2 11 to 50 2017
4 Elemental Machines Elemental Machines provides data-driven insights to improve research, laboratory operations, and manufacturing outcomes. Artificial intelligence Series B $5.7M 2026-05-27 $66.5M Founders Fund, Tau Ventures, Rock Health Capital +2 11 to 50 2015
5 Kytopen Kytopen develops genome engineering platforms for cell therapy research and manufacturing. Biotech Series B $1.6M 2026-04-07 $39.1M National Science Foundation, MassVentures, Alexandria Venture Investments +1 11 to 50 2017

Table 2. Biotech startups that raised Series B in Cambridge, Massachusetts: the 5 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Alexandria Venture Investments Venture capital firm Pasadena, United States 3 4% 1 Kytopen
2 MassVentures Venture capital firm Boston, United States 2 3% 1 Kytopen
3 F-Prime Venture capital firm Cambridge, United States 2 3% 1 Nocion Therapeutics
4 ARCH Venture Partners Venture capital firm Chicago, United States 2 3%
5 Andreessen Horowitz Venture capital firm Menlo Park, United States 2 3%
6 Casdin Capital Venture capital firm New York, United States 2 3%
7 PagodaTree Partners Private equity firm Beijing, China 1 1% 1 Simnova
8 Guochuang Qinzhi Venture capital firm 1 1% 1 Simnova
9 Oriza Seed Capital (Oriza Yuandian) Venture capital firm Suzhou, China 1 1% 1 Simnova
10 Youshan Capital Private equity firm Beijing, China 1 1% 1 Simnova
11 Digitalis Ventures Venture capital firm New York, United States 1 1% 1 Elemental Machines
12 Tau Ventures Venture capital firm Palo Alto, United States 1 1% 1 Elemental Machines
13 KdT Ventures Venture capital firm Austin, United States 1 1% 1 Elemental Machines
14 Rock Health Capital Venture capital firm San Francisco, United States 1 1% 1 Elemental Machines
15 Founders Fund Venture capital firm San Francisco, United States 1 1% 1 Elemental Machines

Table 3. Biotech startups that raised Series B in Cambridge, Massachusetts: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 66 97% $7.8B
Software 5 7% $495.2M
Artificial intelligence 3 4% $432.7M
Hardware 1 1% $34.8M

Table 4. Biotech startups that raised Series B in Cambridge, Massachusetts by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series B 68 100% $50.0M

Table 5. Biotech startups that raised Series B in Cambridge, Massachusetts by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 8% $150.0M
August 2026 1 8% $59.3M
June 2026 2 17% $161.5M
May 2026 2 17% $127.7M
April 2026 1 8% $1.6M
March 2026 2 17% $117.0M
January 2026 3 25% $121.0M

Table 6. Biotech startups that raised Series B in Cambridge, Massachusetts: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 12 18% $738.1M
2025 5 7% $537.0M
2024 3 4% $162.5M
2023 10 15% $862.0M
2022 5 7% $387.0M
2021 5 7% $790.0M

Table 7. Biotech startups that raised Series B in Cambridge, Massachusetts by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 3 4%
2020 to 2022 15 22%
2015 to 2019 27 40%
2010 to 2014 10 15%
Before 2010 13 19%

Table 8. Biotech startups that raised Series B in Cambridge, Massachusetts by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 7 10%
11 to 50 38 56%
51 to 100 18 26%
101 to 250 3 4%
251 to 500 1 1%
10,001 or more 1 1%

Table 9. Biotech startups that raised Series B in Cambridge, Massachusetts by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in Cambridge, Massachusetts whose last round is Series B are on the list?
68, in the file dated 16 November 2026. 12 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 68 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series B in Cambridge, Massachusetts: 68 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in Cambridge

Other sectors that raised Series B in Cambridge

Cite: FundingWatcher, 68 biotech companies in Cambridge, Massachusetts whose most recent round is Series B, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-b/cambridge-massachusetts/